Search research articles
Contact Us
Filters
Showing results (31-40 of 52) with videos related to
Page
of 6
Sort By:
Nuklearmedizin. Nuclear Medicine
|
August 6, 2025
Overview of selected completed prospective studies on PSMA-targeted radioligand therapy with [177Lu]Lu-PSMA-617 in metastatic castration-resistant prostate cancer
Amir Karimzadeh, Wencke Lehnert, Daniel Koehler, et al.
European Journal of Radiology
|
May 13, 2021
Time series analysis of the in-hospital diagnostic process in suspected pulmonary embolism evaluated by computed tomography: An explorative study
Daniel Koehler, Ann-Kathrin Ozga, Isabel Molwitz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 25, 2023
Delayed Imaging Improves Lesion Detectability in [<sup>99m</sup>Tc]Tc-PSMA-I&S SPECT/CT in Recurrent Prostate Cancer
Christoph Berliner, Lisa Steinhelfer, Maythinee Chantadisai, et al.
The Prostate
|
September 2, 2024
Bimodal imaging: Detection rate of clinically significant prostate cancer is higher in MRI lesions visible to transrectal ultrasound
Fabian Falkenbach, Fatima Ahmad-Sterkau, Mykyta Kachanov, et al.
Cancers
|
March 13, 2024
Tumor Response Evaluation Using iRECIST: Feasibility and Reliability of Manual Versus Software-Assisted Assessments
Inka Ristow, Lennart Well, Nis Jesper Wiese, et al.
World Journal of Urology
|
April 24, 2024
Limited prognostic role of routine serum markers (AP, CEA, LDH and NSE) in oligorecurrent prostate cancer patients undergoing PSMA-radioguided surgery
Gisa Mehring, Christina Steinbach, Randi Pose, et al.
The Prostate
|
May 23, 2025
Reply - Letter to the Editor: Bimodal Imaging at MRI Fusion Prostate Biopsy Will Gain Further Importance in the Future
Fabian Falkenbach, Fatima Ahmad-Sterkau, Mykyta Kachanov, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 26, 2023
Prostate-specific membrane antigen radioguided surgery with negative histopathology: an in-depth analysis
Daniel Koehler, Samuel Trappe, Farzad Shenas, et al.
Prostate Cancer and Prostatic Diseases
|
June 4, 2025
Perspective transition from transrectal to transperineal MRI-fusion biopsy under local anesthesia - the institutional TREXIT learning curve of the new gold standard
Fabian Falkenbach, Lukas Hohenhorst, Mykyta Kachanov, et al.
The Prostate
|
October 9, 2024
Size and SUV<sub>max</sub> define the contribution of nodal metastases to PSA in oligorecurrent prostate cancer
Fabian Falkenbach, Marie-Lena Schmalhofer, Zhe Tian, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 52) with videos related to
Sort By:
Page
of 6
Nuklearmedizin. Nuclear Medicine
|
August 6, 2025
Overview of selected completed prospective studies on PSMA-targeted radioligand therapy with [177Lu]Lu-PSMA-617 in metastatic castration-resistant prostate cancer
Amir Karimzadeh, Wencke Lehnert, Daniel Koehler, et al.
European Journal of Radiology
|
May 13, 2021
Time series analysis of the in-hospital diagnostic process in suspected pulmonary embolism evaluated by computed tomography: An explorative study
Daniel Koehler, Ann-Kathrin Ozga, Isabel Molwitz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 25, 2023
Delayed Imaging Improves Lesion Detectability in [<sup>99m</sup>Tc]Tc-PSMA-I&S SPECT/CT in Recurrent Prostate Cancer
Christoph Berliner, Lisa Steinhelfer, Maythinee Chantadisai, et al.
The Prostate
|
September 2, 2024
Bimodal imaging: Detection rate of clinically significant prostate cancer is higher in MRI lesions visible to transrectal ultrasound
Fabian Falkenbach, Fatima Ahmad-Sterkau, Mykyta Kachanov, et al.
Cancers
|
March 13, 2024
Tumor Response Evaluation Using iRECIST: Feasibility and Reliability of Manual Versus Software-Assisted Assessments
Inka Ristow, Lennart Well, Nis Jesper Wiese, et al.
World Journal of Urology
|
April 24, 2024
Limited prognostic role of routine serum markers (AP, CEA, LDH and NSE) in oligorecurrent prostate cancer patients undergoing PSMA-radioguided surgery
Gisa Mehring, Christina Steinbach, Randi Pose, et al.
The Prostate
|
May 23, 2025
Reply - Letter to the Editor: Bimodal Imaging at MRI Fusion Prostate Biopsy Will Gain Further Importance in the Future
Fabian Falkenbach, Fatima Ahmad-Sterkau, Mykyta Kachanov, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 26, 2023
Prostate-specific membrane antigen radioguided surgery with negative histopathology: an in-depth analysis
Daniel Koehler, Samuel Trappe, Farzad Shenas, et al.
Prostate Cancer and Prostatic Diseases
|
June 4, 2025
Perspective transition from transrectal to transperineal MRI-fusion biopsy under local anesthesia - the institutional TREXIT learning curve of the new gold standard
Fabian Falkenbach, Lukas Hohenhorst, Mykyta Kachanov, et al.
The Prostate
|
October 9, 2024
Size and SUV<sub>max</sub> define the contribution of nodal metastases to PSA in oligorecurrent prostate cancer
Fabian Falkenbach, Marie-Lena Schmalhofer, Zhe Tian, et al.
Page
of 6